SUVENPHAR.NS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 11:50):

Stats
今日成交量	1 995.00
平均成交量	487 820
市值	167.75B
EPS	INR0 ( 2024-02-05 )
下一个收益日期	( INR0 ) 2024-05-22
Last Dividend	INR5.00 ( 2022-09-09 )
Next Dividend	INR0 ( N/A )
P/E	45.20
ATR14	INR0.787 (0.12%)

音量相关性

長: -0.07 (neutral)

短: 0.76 (moderate)

Signal:(25.52) Neutral

Suven Pharmaceuticals 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Suven Pharmaceuticals 相关性 - 货币/商品

-0.42
( neutral )

-0.26
( neutral )

-0.41
( neutral )

-0.32
( neutral )

-0.13
( neutral )

-0.31
( neutral )

Suven Pharmaceuticals 财务报表

Annual	2022
营收:	INR13.40B
毛利润:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
营收:	INR13.40B
毛利润:	INR7.55B (56.32 %)
EPS:	INR16.16

FY	2022
营收:	INR12.90B
毛利润:	INR7.35B (56.96 %)
EPS:	INR17.83

FY	2021
营收:	INR9.80B
毛利润:	INR5.60B (57.12 %)
EPS:	INR14.23

Financial Reports:

No articles found.

Suven Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR5.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Suven Pharmaceuticals Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.51 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2021-02-17
Last Dividend	INR5.00	2022-09-09
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	INR10.00	--
Avg. Dividend % Per Year	0.37%	--
Score	3.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.51
Div. Directional Score	7.25	--

Next Divdend (Est)
(2024-07-22)

INR0 Estimate 0.00 %

Dividend Stability

0.11 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
2021	INR2.00	0.43%
2022	INR8.00	1.62%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
INDIAGLYCO.NS	Dividend Junior	2023-09-05	Sporadic	20	0.85%
CHOLAHLDNG.NS	Dividend Junior	2023-08-03	Annually	23	0.06%
SANDHAR.NS	Dividend Junior	2023-09-14	Annually	7	0.66%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GLENMARK.NS	Dividend Junior	2023-09-18	Annually	23	0.37%
ASIANPAINT.NS	Dividend Junior	2023-06-09	Semi-Annually	23	0.43%
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.318	1.500	3.65	5.47	[0 - 0.5]
returnOnAssetsTTM	0.180	1.200	3.99	4.79	[0 - 0.3]
returnOnEquityTTM	0.201	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	26.98	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	20.95	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	17.94	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0168	-1.500	9.72	-10.00	[0 - 0.6]
interestCoverageTTM	94.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.86	2.00	8.07	10.00	[0 - 20]
debtEquityRatioTTM	0.0174	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.587	1.000	3.55	3.55	[0.2 - 0.8]
operatingProfitMarginTTM	0.424	1.000	3.51	3.51	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.85	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.567	0.800	9.55	7.64	[0.5 - 2]
Total Score				12.00

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	45.71	1.000	5.48	0	[1 - 100]
returnOnEquityTTM	0.201	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.86	2.00	8.71	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-4.88	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0842	1.000	-0.396	0	[0.1 - 0.5]
Total Score				2.51

Suven Pharmaceuticals

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited.